These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Hypokalemic nephropathy from the chronic use of diuretics and laxatives]. Robeva R; Belovezhdov N; Minkova V; Doĭchinov D Vutr Boles; 1990; 29(3):130-4. PubMed ID: 2284795 [TBL] [Abstract][Full Text] [Related]
8. Ciprofloxacin-induced crystal nephropathy. Kammoun K; Jarraya F; Makni S; Ben Mahmoud L; Kharrat M; Ben Hmida M; Zeghal K; Boudawara T; Hachicha J Iran J Kidney Dis; 2014 May; 8(3):240-2. PubMed ID: 24878949 [TBL] [Abstract][Full Text] [Related]
9. Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity. Perazella MA Am J Med Sci; 2003 Jun; 325(6):349-62. PubMed ID: 12811231 [TBL] [Abstract][Full Text] [Related]
10. Orlistat-induced oxalate nephropathy may be dose-independent and present as a late manifestation. Dossabhoy NR; McRight S; Sangha B; Khan S; Adgeh C J La State Med Soc; 2013; 165(5):283-5. PubMed ID: 24350530 [TBL] [Abstract][Full Text] [Related]
11. Indinavir nephropathy revisited: a pattern of insidious renal failure with identifiable risk factors. Reilly RF; Tray K; Perazella MA Am J Kidney Dis; 2001 Oct; 38(4):E23. PubMed ID: 11576910 [TBL] [Abstract][Full Text] [Related]
13. [Phosphate nephropathy: how to avoid it?]. Bourquin V; Ponte B; Zellweger M; Levy M; Hadengue A; Moll S Rev Med Suisse; 2011 Nov; 7(317):2227-8, 2230-1. PubMed ID: 22400350 [TBL] [Abstract][Full Text] [Related]
14. Acute oxalate nephropathy associated with orlistat, a gastrointestinal lipase inhibitor. Singh A; Sarkar SR; Gaber LW; Perazella MA Am J Kidney Dis; 2007 Jan; 49(1):153-7. PubMed ID: 17185156 [TBL] [Abstract][Full Text] [Related]
15. Renal risks of sodium phosphate tablets for colonoscopy preparation: a review of adverse drug reactions reported to the US Food and Drug Administration. Ehrenpreis ED; Parakkal D; Semer R; Du H Colorectal Dis; 2011 Sep; 13(9):e270-5. PubMed ID: 21689347 [TBL] [Abstract][Full Text] [Related]
16. Application of Imaging Techniques to Cases of Drug-Induced Crystal Nephropathy in Preclinical Studies. Lenz B; Brink A; Siam M; De Paepe A; Bassett S; Eichinger-Chapelon A; Maliver P; Neff R; Niederhauser U; Steinhuber B; Zurbach R; Singer T; Funk C; Schuler F; Albassam M; Schadt S Toxicol Sci; 2018 Jun; 163(2):409-419. PubMed ID: 28329870 [TBL] [Abstract][Full Text] [Related]
17. Drug-induced nephropathy: an update. Perazella MA Expert Opin Drug Saf; 2005 Jul; 4(4):689-706. PubMed ID: 16011448 [TBL] [Abstract][Full Text] [Related]
18. Acute Ciprofloxacin-Induced Crystal Nephropathy with Granulomatous Interstitial Nephritis. Goli R; Mukku KK; Raju SB; Uppin MS Indian J Nephrol; 2017; 27(3):231-233. PubMed ID: 28553048 [TBL] [Abstract][Full Text] [Related]
19. Orlistat and calcium oxalate crystalluria: an association that needs consideration. Ahmed MH Ren Fail; 2010; 32(8):1019-21. PubMed ID: 20722574 [TBL] [Abstract][Full Text] [Related]
20. Weight loss at a high cost: Orlistat-induced late-onset severe kidney disease. Buysschaert B; Aydin S; Morelle J; Hermans MP; Jadoul M; Demoulin N Diabetes Metab; 2016 Feb; 42(1):62-4. PubMed ID: 26454353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]